OptimizeRx Osake

OptimizeRx EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä OptimizeRx (OPRX) 24.7.2026 päivämäärällä on −1,89 M USD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −15,12 M USD — muutos −87,51 % (korkeampi).

EBITDA

−1,89 MUSD

YoY

−87,51%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä OptimizeRx on 2026 −1,89 M USD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä OptimizeRx oli 2025 −15,12 M USD. Se laskee −87,51% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

OptimizeRx Osakeanalyysi

Mitä OptimizeRx tekee? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset OptimizeRx osakkeesta

Yhtiön OptimizeRx EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −1,89 M USD vuonna 2026.

Access this data via the Eulerpool API

Tuloslaskelma — OptimizeRx

Kaikki tunnusluvut — OptimizeRx